Promising effect of aromatase inhibitors on recurrent granulosa cell tumors

International Journal of Gynecological Cancer

Volumn 19, Issue 5, 2009, Pages 830-833

  Korach, Jacob ^a   Perri, Tamar ^b   Beiner, Mario ^b   Davidzon, Tima ^b   Fridman, Eddie ^b   Baruch, Gilad Ben ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Aromatase inhibitor; Granulosa cell tumor; Recurrent

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; BLEOMYCIN; CISPLATIN; ETOPOSIDE; LETROZOLE; NITRILE; TRIAZOLE DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DRUG EFFECT; DRUG WITHDRAWAL; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; FEMALE; GRANULOSA CELL TUMOR; HISTOPATHOLOGY; HUMAN; LAPAROSCOPIC SURGERY; MULTIPLE CYCLE TREATMENT; NEUROPATHY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR RECURRENCE; UNSPECIFIED SIDE EFFECT; MIDDLE AGED; OVARIECTOMY; OVARY TUMOR; PATHOLOGY; PROGNOSIS;

ADULT; AGED; AROMATASE INHIBITORS; FEMALE; GRANULOSA CELL TUMOR; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NITRILES; OVARIAN NEOPLASMS; OVARIECTOMY; PROGNOSIS; TREATMENT OUTCOME; TRIAZOLES;

EID: 69449099018     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a261d7     Document Type: Article

References (23)

1. Brown J, Shvartsman HS, Deavers MT, et al. The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cordYstromal ovarian tumors. Gynecol Oncol. 2005;97:489-496.
2. Wolf JK, Mullen J, Eifel PJ, et al. Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol. 1999;73:35-41.
3. Cohen E, Samant R, Fung MF, et al. Palliative radiotherapy for recurrent granulosa cell tumor of the ovary: a report of 3 cases with radiological evidence of response. Gynecol Oncol. 2006;102: 406-410.
4. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003;21:1180-1189.
5. Colombo N, Parma G, Zanagnolo V, et al. Management of ovarian stromal cell tumors. J Clin Oncol. 2007;25:2944-2951.
6. WillemsenW, Kruitwagen R, Bastiaans B, et al. Ovarian stimulation and granulosa-cell tumour. Lancet. 1993;341:986-988.
7. Hardy RD, Bell JG, Nicely CJ, et al. Hormonal treatment of a recurrent granulosa cell tumor of the ovary: case report and review of the literature. Gynecol Oncol. 2005;96:865-869.
8. Fishman A, Kudelka AP, Tresukosol D, et al. Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor. J Reprod Med. 1996;41:393-396.
9. Freeman SA, Modesitt SC. Anastrozole therapy in recurrent ovarian adult granulosa cell tumors: a report of 2 cases. Gynecol Oncol. 2006;103:755-758.
10. Pecorelli S, Wagenaar HC, Vergote IB, et al. Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC Gynaecological Cancer Cooperative Group study. Eur J Cancer. 1999;35:1331-1337.
11. Gershenson DM, Morris M, Burke TW, et al. Treatment of poor-prognosis sex cordYstromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol. 1996;87:527-531.
12. Zambetti M, Escobedo A, Pilotti S, et al. cis-Platinum/vinblastine/ bleomycin combination chemotherapy in advanced or recurrent granulosa cell tumors of the ovary. Gynecol Oncol. 1990;36: 317-320.
13. Homesley HD, Bundy BN, Hurteau JA, et al. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol. 1999;72:131-137.
14. Tresukosol D, Kudelka AP, Edwards CL, et al. Recurrent ovarian granulosa cell tumor: a case report of a dramatic response to Taxol. Int J Gynecol Cancer. 1995;5:156-159.
15. Kauppila A, Bangah M, Burger H, et al. GnRH agonist analog therapy in advanced/recurrent granulosa cell tumors: further evidence of a role of inhibin in monitoring response to treatment. Gynecol Endocrinol. 1992;6:271-274.
16. Maxwell GL, Soisson AP, Miles P. Failure of gonadotropin releasinghormone therapy in patients with metastatic ovarian sex cord stromal tumors. Oncology. 1994;51:356-359.
17. Ameryckx L, Fatemi HM, De Sutter P, et al. GnRH antagonist in the adjuvant treatment of a recurrent ovarian granulosa cell tumor: a case report. Gynecol Oncol. 2005;99:764-766.
18. Briasoulis E, Karavasilis V, Pavlidis N. Megestrol activity in recurrent adult type granulosa cell tumour of the ovary. Ann Oncol. 1997;8:811-812.
19. Iwase H. Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer. Breast Cancer. 2008;15:278-290.
20. Krasner C. Aromatase inhibitors in gynecologic cancers. J Steroid Biochem Mol Biol. 2007;106:76-80.
21. Krauss K, Bachmann C, Hartmann JT, et al. Management of late recurrence of a low-grade endometrial stromal sarcoma (LGESS): treatment with letrozole. Anticancer Res. 2007;27:3477-3480.
22. Reich O, Regauer S. Hormonal therapy of endometrial stromal sarcoma. Curr Opin Oncol. 2007;19:347-352.
23. Rose PG, Brunetto VL, VanLe L, et al. A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2000;78: 212-216.